Skip to main content
Premium Trial:

Request an Annual Quote

Interpace Diagnostics MVPdX Lung Cancer Test

Interpace Diagnostics has launched a new lung cancer test, MVPdX, that  compares the mutational fingerprint of two or more sites of lung cancer to differentiate new primary lung tumors from recurrences or metastases. The assay is based on an analysis of loss of heterozygosity via a panel of microsatellite markers in proximity to 16 tumor suppressor genes.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.